1 Min Read
April 25 (Reuters) - Sangamo Therapeutics Inc
* Sangamo announces the retirement of its founder and genome editing pioneer Edward Lanphier from the board of directors Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.